Dr. Aaron D. Berger, M.D.
Urology (Urology Physician)
10400 Southwest Hwy
Chicago Ridge, IL 60415
Who else practices at this address →
Cook County includes primary care (3% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of California, Geffen School of Medicine (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 1,148
Licensed in Illinois since 2008, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: University of California, Geffen School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
IL license 036120732 (first issued 2008; active) · CA license A98717
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Northwestern Medicine Central Dupage Hospital Winfield, IL
- Palos Community Hospital Palos Heights, IL
- Advocate Christ Hospital & Medical Center Oak Lawn, IL
- Silver Cross Hospital and Medical Centers New Lenox, IL
- Advocate Trinity Hospital Chicago, IL
Medical groups
- Uropartners LLC (138 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,148
- Services billed
- 29,420
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Injection, denosumab, 1 mg | 8,580 | 47 |
| Leuprolide injectable, camcevi, 1 mg | 4,620 | 72 |
| Injection, onabotulinumtoxina, 1 unit | 3,300 | 13 |
| Bcg live intravesical instillation, 1 mg | 1,351 | 12 |
| Established patient office or other outpatient visit, 30-39 minutes | 997 | 612 |
| Automated urinalysis test | 753 | 506 |
| Ultrasound measurement of bladder capacity after voiding | 532 | 399 |
| Detection test by nucleic acid for organism, amplified probe technique | 494 | 36 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 440 | 69 |
| Insertion of needle into vein for collection of blood sample | 320 | 203 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Chicago Ridge, IL | 941 |
| Erleada (apalutamide) | 617 |
| Orgovyx (relugolix) | 495 |
| Xtandi (enzalutamide) | 481 |
| Oxybutynin Chloride Er (oxybutynin chloride) Other prescribers in Chicago Ridge, IL | 352 |
| Finasteride Other prescribers in Chicago Ridge, IL | 275 |
| Solifenacin Succinate Other prescribers in Chicago Ridge, IL | 246 |
| Abiraterone Acetate | 200 |
| Nubeqa (darolutamide) | 199 |
| Prednisone Other prescribers in Chicago Ridge, IL | 179 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 30 companies reported 362 payments worth $176,899 in total to this clinician.
| Janssen Biotech, Inc. | $58,542 |
|---|---|
| Ferring Pharmaceuticals Inc. | $38,926 |
| Bayer HealthCare Pharmaceuticals Inc. | $19,155 |
| Astellas Pharma US Inc | $16,490 |
| Bioprotect Medical, Inc. | $14,053 |
| Pfizer Inc. | $11,918 |
| Accord Healthcare, Inc. | $6,938 |
| Sumitomo Pharma America, Inc. | $4,145 |
| Compensation for services other than consulting (speaking, faculty) | $117,163 |
|---|---|
| Consulting Fee | $30,936 |
| Travel and Lodging | $16,938 |
| Food and Beverage | $9,237 |
| Honoraria | $2,590 |
| Education | $35.06 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. May 23, 2025 | Compensation for services other than consulting (speaking, faculty) Nubeqa · Oncology | $6,762 |
| Accord Healthcare, Inc. May 17, 2025 | Consulting Fee Camcevi · Urology Oncology – GnRH agonist for treating adults with advanced prostate cance | $6,458 |
| Bayer HealthCare Pharmaceuticals Inc. Aug 7, 2025 | Consulting Fee Nubeqa · Oncology | $5,232 |
| Astellas Pharma US Inc Sep 20, 2025 | Compensation for services other than consulting (speaking, faculty) Xtandi · Oncology | $4,550 |
| Ferring Pharmaceuticals Inc. Oct 9, 2025 | Compensation for services other than consulting (speaking, faculty) ADSTILADRIN · ONCOLOGY | $4,550 |
| Ferring Pharmaceuticals Inc. Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) ADSTILADRIN · ONCOLOGY | $4,550 |
| Ferring Pharmaceuticals Inc. Dec 18, 2025 | Compensation for services other than consulting (speaking, faculty) ADSTILADRIN · ONCOLOGY | $4,550 |
| Janssen Biotech, Inc. Nov 3, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $4,163 |
| Janssen Biotech, Inc. Jun 7, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $4,163 |
| Janssen Biotech, Inc. Sep 15, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $4,163 |
All 115 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Dec 23, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to San Antonio, TX | $149 |
| Janssen Biotech, Inc. Dec 23, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to San Antonio, TX | $55.00 |
| Janssen Biotech, Inc. Dec 23, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to San Antonio, TX | $14.49 |
| Janssen Biotech, Inc. Dec 23, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to San Antonio, TX | $13.02 |
| Ferring Pharmaceuticals Inc. Dec 22, 2025 | Compensation for services other than consulting (speaking, faculty) ADSTILADRIN · ONCOLOGY | $1,470 |
| Ferring Pharmaceuticals Inc. Dec 18, 2025 | Compensation for services other than consulting (speaking, faculty) ADSTILADRIN · ONCOLOGY | $4,550 |
| Ferring Pharmaceuticals Inc. Dec 1, 2025 | Travel and Lodging ADSTILADRIN · ONCOLOGY · travel to ORLANDO, FL · in-kind | $320 |
| Ferring Pharmaceuticals Inc. Nov 30, 2025 | Travel and Lodging ADSTILADRIN · ONCOLOGY · travel to BURR RIDGE, IL · in-kind | $462 |
| Janssen Biotech, Inc. Nov 27, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $4,163 |
| Bioprotect Medical, Inc. Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) BIOPROTECT BALLOON IMPLANT SYSTEM · Rectal Spacers Used in Prostate Cancer Radiation Therapy | $1,000 |
| Janssen Biotech, Inc. Nov 14, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $3,608 |
| Bioprotect Medical, Inc. Nov 14, 2025 | Compensation for services other than consulting (speaking, faculty) BIOPROTECT BALLOON IMPLANT SYSTEM · Rectal Spacers Used in Prostate Cancer Radiation Therapy | $2,000 |
| Janssen Biotech, Inc. Nov 14, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Oak Brook, IL | $7.14 |
| AstraZeneca Pharmaceuticals LP Nov 13, 2025 | Education IMFINZI · Oncology · in-kind Company’s descriptionJournal Article | $35.06 |
| Janssen Biotech, Inc. Nov 4, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Sioux Falls, SD | $59.30 |
| Janssen Biotech, Inc. Nov 4, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Sioux Falls, SD | $43.00 |
| Janssen Biotech, Inc. Nov 4, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Sioux Falls, SD | $26.60 |
| Janssen Biotech, Inc. Nov 3, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $4,163 |
| Ferring Pharmaceuticals Inc. Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) ADSTILADRIN · ONCOLOGY | $4,550 |
| Pfizer Inc. Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) XTANDI · ONCOLOGY | $2,400 |
| Janssen Biotech, Inc. Oct 30, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Sioux Falls, SD · in-kind | $187 |
| Pfizer Inc. Oct 29, 2025 | Travel and Lodging XTANDI · ONCOLOGY · travel to Merrillville, IN · in-kind | $68.60 |
| Ferring Pharmaceuticals Inc. Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) ADSTILADRIN · ONCOLOGY | $1,400 |
| Ferring Pharmaceuticals Inc. Oct 17, 2025 | Travel and Lodging ADSTILADRIN · ONCOLOGY · travel to BURR RIDGE, IL · in-kind | $86.00 |
| Ferring Pharmaceuticals Inc. Oct 17, 2025 | Travel and Lodging ADSTILADRIN · ONCOLOGY · travel to BURR RIDGE, IL · in-kind | $25.20 |
| Ferring Pharmaceuticals Inc. Oct 16, 2025 | Travel and Lodging ADSTILADRIN · ONCOLOGY · travel to BURR RIDGE, IL · in-kind | $511 |
| Ferring Pharmaceuticals Inc. Oct 16, 2025 | Travel and Lodging ADSTILADRIN · ONCOLOGY · travel to NASHVILLE, TN · in-kind | $445 |
| Ferring Pharmaceuticals Inc. Oct 9, 2025 | Compensation for services other than consulting (speaking, faculty) ADSTILADRIN · ONCOLOGY | $4,550 |
| Urogen Pharma, Inc. Oct 6, 2025 | Honoraria ZUSDURI · LG-IR-NMIBC · in-kind | $2,590 |
| Janssen Biotech, Inc. Oct 6, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to San Antonio, TX · in-kind | $396 |
| Janssen Biotech, Inc. Oct 3, 2025 | Consulting Fee ERLEADA · Oncology | $1,388 |
| Janssen Biotech, Inc. Sep 25, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Sioux Falls, SD · in-kind | $506 |
| Bayer HealthCare Pharmaceuticals Inc. Sep 25, 2025 | Consulting Fee Nubeqa · Oncology | $218 |
| Astellas Pharma US Inc Sep 20, 2025 | Compensation for services other than consulting (speaking, faculty) Xtandi · Oncology | $4,550 |
| Astellas Pharma US Inc Sep 20, 2025 | Travel and Lodging Xtandi · Oncology · travel to Santa Fe, NM | $729 |
| Astellas Pharma US Inc Sep 20, 2025 | Travel and Lodging Xtandi · Oncology · travel to Santa Fe, NM | $536 |
| Astellas Pharma US Inc Sep 20, 2025 | Travel and Lodging Xtandi · Oncology · travel to Santa Fe, NM | $334 |
| Bioprotect Medical, Inc. Sep 16, 2025 | Compensation for services other than consulting (speaking, faculty) BIOPROTECT BALLOON IMPLANT SYSTEM · Rectal Spacers Used in Prostate Cancer Radiation Therapy | $3,500 |
| Bayer HealthCare Pharmaceuticals Inc. Sep 16, 2025 | Compensation for services other than consulting (speaking, faculty) Nubeqa · Oncology | $1,176 |
| Janssen Biotech, Inc. Sep 15, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $4,163 |
| Ferring Pharmaceuticals Inc. Sep 12, 2025 | Consulting Fee ADSTILADRIN · ONCOLOGY | $3,850 |
| Janssen Biotech, Inc. Sep 12, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Saint Louis, MO | $272 |
| Astellas Pharma US Inc Sep 10, 2025 | Compensation for services other than consulting (speaking, faculty) Xtandi · Oncology | $3,250 |
| Astellas Pharma US Inc Sep 10, 2025 | Travel and Lodging Xtandi · Oncology · travel to Orland Park, IL | $25.20 |
| Astellas Pharma US Inc Sep 8, 2025 | Compensation for services other than consulting (speaking, faculty) Xtandi · Oncology | $3,900 |
| Bioprotect Medical, Inc. Sep 8, 2025 | Travel and Lodging BIOPROTECT BALLOON IMPLANT SYSTEM · Rectal Spacers Used in Prostate Cancer Radiation Therapy · travel to Detroit, MI | $942 |
| Astellas Pharma US Inc Sep 8, 2025 | Travel and Lodging Xtandi · Oncology · travel to Nashville, TN | $477 |
| Astellas Pharma US Inc Sep 8, 2025 | Travel and Lodging Xtandi · Oncology · travel to Nashville, TN | $237 |
| Janssen Scientific Affairs, LLC Sep 3, 2025 | Consulting Fee | $1,150 |
| Janssen Scientific Affairs, LLC Sep 3, 2025 | Travel and Lodging travel to CHICAGO, IL | $32.20 |
| Janssen Scientific Affairs, LLC Sep 3, 2025 | Travel and Lodging travel to CHICAGO, IL | $9.50 |
| Ferring Pharmaceuticals Inc. Aug 14, 2025 | Travel and Lodging ADSTILADRIN · ONCOLOGY · travel to CHICAGO, IL · in-kind | $38.29 |
| Bayer HealthCare Pharmaceuticals Inc. Aug 7, 2025 | Consulting Fee Nubeqa · Oncology | $5,232 |
| Ferring Pharmaceuticals Inc. Jul 30, 2025 | Compensation for services other than consulting (speaking, faculty) ADSTILADRIN · ONCOLOGY | $3,850 |
| Janssen Biotech, Inc. Jul 28, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Saint Louis, MO · in-kind | $293 |
| Ferring Pharmaceuticals Inc. Jul 18, 2025 | Travel and Lodging ADSTILADRIN · ONCOLOGY · travel to ROMULUS, MI · in-kind | $315 |
| Ferring Pharmaceuticals Inc. Jul 18, 2025 | Travel and Lodging ADSTILADRIN · ONCOLOGY · travel to ROMULUS, MI · in-kind | $188 |
| Ferring Pharmaceuticals Inc. Jul 16, 2025 | Travel and Lodging ADSTILADRIN · ONCOLOGY · travel to ROMULUS, MI · in-kind | $298 |
| Janssen Biotech, Inc. Jul 12, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $4,163 |
| Ferring Pharmaceuticals Inc. Jul 10, 2025 | Compensation for services other than consulting (speaking, faculty) ADSTILADRIN · ONCOLOGY | $3,850 |
| Janssen Biotech, Inc. Jul 9, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to De Pere, WI · in-kind | $947 |
| Bayer HealthCare Pharmaceuticals Inc. Jul 3, 2025 | Compensation for services other than consulting (speaking, faculty) Nubeqa · Oncology | $1,176 |
| Ferring Pharmaceuticals Inc. Jul 2, 2025 | Compensation for services other than consulting (speaking, faculty) ADSTILADRIN · ONCOLOGY | $1,400 |
| Janssen Biotech, Inc. Jun 27, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $3,608 |
| Bioprotect Medical, Inc. Jun 27, 2025 | Travel and Lodging BIOPROTECT BALLOON IMPLANT SYSTEM · Rectal Spacers Used in Prostate Cancer Radiation Therapy · travel to Chicago, IL | $750 |
| Janssen Biotech, Inc. Jun 27, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Orland Park, IL | $23.80 |
| Ferring Pharmaceuticals Inc. Jun 26, 2025 | Travel and Lodging ADSTILADRIN · ONCOLOGY · travel to BURR RIDGE, IL · in-kind | $1,058 |
| Janssen Biotech, Inc. Jun 26, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to De Pere, WI · in-kind | $5.50 |
| Bioprotect Medical, Inc. Jun 23, 2025 | Consulting Fee BIOPROTECT BALLOON IMPLANT SYSTEM · Rectal Spacers Used in Prostate Cancer Radiation Therapy | $3,000 |
| Janssen Biotech, Inc. Jun 7, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $4,163 |
| Janssen Biotech, Inc. Jun 7, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Springfield, MO | $65.80 |
| Janssen Biotech, Inc. Jun 7, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Springfield, MO | $56.53 |
| Janssen Biotech, Inc. Jun 7, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Springfield, MO | $29.40 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 6, 2025 | Travel and Lodging Nubeqa · Oncology · travel to Las Vegas, NV · in-kind | $181 |
| Janssen Biotech, Inc. Jun 4, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Springfield, MO · in-kind | $134 |
| Accord Healthcare, Inc. Jun 3, 2025 | Consulting Fee Camcevi · Urology Oncology – GnRH agonist for treating adults with advanced prostate cance | $461 |
| Pfizer Inc. Jun 2, 2025 | Consulting Fee TALZENNA · ONCOLOGY | $1,800 |
| Janssen Biotech, Inc. May 28, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $694 |
| Bayer HealthCare Pharmaceuticals Inc. May 23, 2025 | Compensation for services other than consulting (speaking, faculty) Nubeqa · Oncology | $6,762 |
| Janssen Biotech, Inc. May 21, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $416 |
| Accord Healthcare, Inc. May 17, 2025 | Consulting Fee Camcevi · Urology Oncology – GnRH agonist for treating adults with advanced prostate cance | $6,458 |
| Bayer HealthCare Pharmaceuticals Inc. May 14, 2025 | Consulting Fee Nubeqa · Oncology | $436 |
| Janssen Biotech, Inc. May 13, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Springfield, MO · in-kind | $498 |
| Ferring Pharmaceuticals Inc. May 8, 2025 | Compensation for services other than consulting (speaking, faculty) ADSTILADRIN · ONCOLOGY | $2,100 |
| Ferring Pharmaceuticals Inc. May 8, 2025 | Compensation for services other than consulting (speaking, faculty) ADSTILADRIN · ONCOLOGY | $633 |
| Bioprotect Medical, Inc. May 6, 2025 | Compensation for services other than consulting (speaking, faculty) BIOPROTECT BALLOON IMPLANT SYSTEM · Rectal Spacers Used in Prostate Cancer Radiation Therapy | $2,000 |
| Astellas Pharma US Inc May 6, 2025 | Compensation for services other than consulting (speaking, faculty) Xtandi · Oncology | $1,950 |
| Janssen Biotech, Inc. Apr 10, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Omaha, NE · in-kind | $345 |
| Ferring Pharmaceuticals Inc. Apr 9, 2025 | Consulting Fee ADSTILADRIN · ONCOLOGY | $1,899 |
| Janssen Biotech, Inc. Apr 2, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $4,163 |
| Janssen Biotech, Inc. Apr 2, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $4,163 |
| Janssen Biotech, Inc. Apr 2, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $4,163 |
| Janssen Biotech, Inc. Apr 2, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Bloomington, MN | $149 |
| Janssen Biotech, Inc. Apr 2, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Irving, TX | $141 |
| Bayer HealthCare Pharmaceuticals Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) Nubeqa · Oncology | $588 |
| Janssen Biotech, Inc. Mar 26, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Indianapolis, IN · in-kind | $764 |
| Bayer HealthCare Pharmaceuticals Inc. Mar 19, 2025 | Travel and Lodging Nubeqa · Oncology · travel to Las Vegas, NV · in-kind | $523 |
| Janssen Biotech, Inc. Mar 15, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $3,608 |
| Janssen Biotech, Inc. Mar 14, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Oak Brook, IL | $8.96 |
| Janssen Biotech, Inc. Mar 13, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Indianapolis, IN · in-kind | $5.50 |
| Janssen Biotech, Inc. Mar 10, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Indianapolis, IN · in-kind | $5.50 |
| Janssen Biotech, Inc. Mar 3, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Bloomington, MN · in-kind | $315 |
| Pfizer Inc. Feb 19, 2025 | Compensation for services other than consulting (speaking, faculty) XTANDI · ONCOLOGY | $3,750 |
| Pfizer Inc. Feb 14, 2025 | Travel and Lodging XTANDI · ONCOLOGY · travel to Aspen, CO · in-kind | $41.59 |
| Sumitomo Pharma America, Inc. Feb 12, 2025 | Compensation for services other than consulting (speaking, faculty) ORGOVYX · PROSTATE CANCER | $3,575 |
| Sumitomo Pharma America, Inc. Feb 12, 2025 | Travel and Lodging ORGOVYX · PROSTATE CANCER · travel to ROCKFORD, IL | $109 |
| Sumitomo Pharma America, Inc. Feb 12, 2025 | Travel and Lodging ORGOVYX · PROSTATE CANCER · travel to ROCKFORD, IL | $6.50 |
| Pfizer Inc. Feb 11, 2025 | Travel and Lodging XTANDI · ONCOLOGY · travel to Aspen, CO · in-kind | $807 |
| Pfizer Inc. Feb 8, 2025 | Travel and Lodging XTANDI · ONCOLOGY · travel to Aspen, CO · in-kind | $736 |
| Janssen Biotech, Inc. Jan 24, 2025 | Consulting Fee ERLEADA; AKEEGA · Oncology | $3,300 |
| Bayer HealthCare Pharmaceuticals Inc. Jan 16, 2025 | Consulting Fee Nubeqa · Oncology | $1,744 |
| Bayer HealthCare Pharmaceuticals Inc. Jan 16, 2025 | Travel and Lodging Nubeqa · Oncology · travel to Miami, FL · in-kind | $507 |
| Janssen Biotech, Inc. Jan 16, 2025 | Travel and Lodging ERLEADA; AKEEGA · Oncology · travel to MIAMI, FL · in-kind | $417 |
| Bayer HealthCare Pharmaceuticals Inc. Jan 16, 2025 | Travel and Lodging Nubeqa · Oncology · travel to Miami, FL · in-kind | $207 |
| Pfizer Inc. Jan 13, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,000 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 3 companies. The companies reported $831,681 in research payments for these studies, mostly to the institutions running them.
- A Phase 3, Open-label, Randomized, Prospective Study of Apalutamide Monotherapy Versus Apalutamide Plus Androgen Deprivation Therapy (ADT) in Participants Newly Diagnosed with Metastatic Castration-Sensitive Prostate …
Janssen Research & Development, LLC - Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Dendreon Pharmaceuticals LLC · Recruiting · NCT06134232 - Phase 1 Study of Erdafitinib Intravesical Delivery System (TAR-210) in Participants with Non-Muscle-Invasive or Muscle-Invasive Bladder Cancer and Selected FGFR Mutations or Fusions
Janssen Research & Development, LLC - Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate
Sumitomo Pharma America, Inc. · Completed · NCT05605964 - A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX
Sumitomo Pharma America, Inc. · Completed · NCT05467176
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.